Here’s a preview of the featured content to watch for this week on Drug Topics®.
Coronavirus Research News
With an estimated 52.9 million coronavirus disease 2019 (COVID-19) vaccine doses administered as of this article’s press time and more than 59 million doses delivered in the United States, keeping up with pandemic news is more important than ever. Check back to Drug Topics® to stay informed on the latest coronavirus-related news and research.
American Heart Month
February is American Heart Month. Check out our Heart Health section for the latest news and research on cardiovascular-related issues, including COVID-19 effects on heart disease risk.
Medical World News Updates
Drug Topics® interviewed Kaitlyn Rivard, PharmD, infectious diseases clinical pharmacist at the Cleveland Clinic, on her role in getting their COVID-19 vaccination program off the ground. Rivard discusses key insights, advice, and experience in developing an effective COVID-19 vaccination program.
Lee Rosebush of BakerHostetler law firm discussed with Drug Topics® their interactive state-by-state COVID-19 vaccine rollout guide, as well as issues related to regulation and compliance for pharmacies amid the pandemic.
Upcoming Webinar on Integrating CBD Into Your Pharmacy
Don’t miss our next webinar with Chris Howard, VP, general counsel and chief compliance officer, and Mike Sullivan, director, trade marketing of E-Alternative Solutions (EAS), who will be joining Drug Topics® for this 1-hour webinar to address these concerns and equip you with the knowledge to effectively navigate the CBD industry.
Drug Topics® Journal, February 2021 Digital Edition
The February 2021 digital edition of Drug Topics Journal is now available on DrugTopics.com. In this issue, pharmacists share tips for engaging with patients online, and our cover story highlights practicing culturally competent care to fight health disparities.
In Case You Missed It: Gallup Poll Finds Many Americans Dissatisfied With COVID-19 Vaccine Rollout
The survey results also showed an increasing willingness among Americans to receive the vaccine.